Showing results (51-60 of 131) with videos related to
Sort By:
Pageof 14
Annals of Internal Medicine|November 4, 2014
Re-treatment of chronic hepatitis C virus genotype 1 infection after relapse: an open-label pilot studyAnu Osinusi, Anita Kohli, Miriam M Marti, et al.Gastroenterology|August 7, 2015
Efficacy of sofosbuvir plus ribavirin with or without peginterferon-alfa in patients with hepatitis C virus genotype 3 infection and treatment-experienced patients with cirrhosis and hepatitis C virus genotype 2 infectionGraham R Foster, Stephen Pianko, Ashley Brown, et al.The New England Journal of Medicine|July 10, 2009
Raxibacumab for the treatment of inhalational anthraxThi-Sau Migone, G Mani Subramanian, John Zhong, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 25, 2016
Efficacy and Safety of Sofosbuvir/Velpatasvir in Patients With Chronic Hepatitis C Virus Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ASTRAL TrialsJason Grebely, Gregory J Dore, Stefan Zeuzem, et al.Lancet (London, England)|February 10, 2015
Sofosbuvir plus ribavirin for treatment of hepatitis C virus in patients co-infected with HIV (PHOTON-2): a multicentre, open-label, non-randomised, phase 3 studyJean-Michel Molina, Chloe Orkin, David M Iser, et al.Journal of Hepatology|February 21, 2006
A phase 2 study to evaluate the antiviral activity, safety, and pharmacokinetics of recombinant human albumin-interferon alfa fusion protein in genotype 1 chronic hepatitis C patientsVincent G Bain, Kelly D Kaita, Eric M Yoshida, et al.Antiviral Therapy|August 9, 2014
Safety, pharmacokinetics and pharmacodynamics of the oral toll-like receptor 7 agonist GS-9620 in treatment-naive patients with chronic hepatitis CEric Lawitz, Daniel Gruener, Thomas Marbury, et al.Gastroenterology|December 26, 2013
Randomized comparison of tenofovir disoproxil fumarate vs emtricitabine and tenofovir disoproxil fumarate in patients with lamivudine-resistant chronic hepatitis BScott Fung, Peter Kwan, Milotka Fabri, et al.Hepatology (Baltimore, Md.)|April 8, 2015
Sofosbuvir plus pegylated interferon and ribavirin in patients with genotype 1 hepatitis C virus in whom previous therapy with direct-acting antivirals has failedStanislas Pol, Mark S Sulkowski, Tarek Hassanein, et al.World Journal of Gastroenterology|December 8, 2011
FibroSURE and FibroScan in relation to treatment response in chronic hepatitis C virusKeyur Patel, Mireen Friedrich-Rust, Yoav Lurie, et al.Pageof 14